Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aurora Spine Corp V.ASG

Alternate Symbol(s):  ASAPF

Aurora Spine Corporation is a designer and manufacturer of medical devices. The Company is engaged in the development and distribution of minimally invasive, interspinous fusion systems and devices. It offers a range of devices specifically designed to address cervical spine conditions and restore optimal functionality. Its Cervical product line includes apollo, Discovery, and DEXA-C. The... see more

Recent & Breaking News (TSXV:ASG)

Aurora Spine Corporation Announces Positive Interim Results from Clinical Study using ZIP(TM) MIS Interspinous Fusion System

GlobeNewswire October 27, 2022

Aurora Spine Corporation to Attend the North American Spine Society (NASS) Annual Meeting

GlobeNewswire October 11, 2022

Aurora Spine Receives 2022 Best New Spine Technology Award for its DEXA bone density-matched spine implant innovation

GlobeNewswire October 11, 2022

Aurora Spine Corporation Announces FDA 510(k) Clearance for its SiLO TFX(TM) MIS Sacroiliac Joint Fixation System

GlobeNewswire October 6, 2022

Aurora Spine Corporation Announces FDA 510(k) Clearance for its SiLO TFX(TM) MIS Sacroiliac Joint Fixation System

GlobeNewswire October 4, 2022

Aurora Spine Corporation to Participate in the Lytham Partners Fall 2022 Investor Conference

GlobeNewswire September 20, 2022

Aurora Spine (TSXV:ASG) announces record Q2 2022 financial results

Shoran Devi August 29, 2022

Aurora Spine Corporation Announces Record Second Quarter Fiscal 2022 Financial Results

GlobeNewswire August 29, 2022

Aurora Spine Corporation Schedules Release of Second Quarter Fiscal Year 2022 Financial Results and Conference Call

GlobeNewswire August 22, 2022

Aurora Spine Announces New FDA indication clearance of Lumbar Spinal Stenosis for its ZIP(TM) series of MIS implants

GlobeNewswire July 12, 2022

Aurora Spine Corporation Issued Patent by USPTO For Its Interlaminar Single Implant Technology For Motion Preservation or Fusion

GlobeNewswire June 13, 2022

Aurora Spine (TSXV:ASG) receives FDA 510(k) clearance

Shoran Devi June 6, 2022

Aurora Spine Corporation Receives FDA 510(k) Clearance for DEXA SOLO-LTM Anterior Lumbar Interbody Fusion Device as part of its DEXA Technology Platform

GlobeNewswire June 6, 2022

Aurora Spine Corporation Announces Record First Quarter Fiscal 2022 Financial Results

GlobeNewswire May 24, 2022

Aurora Spine Corporation Schedules Release for First Quarter Fiscal Year 2022 Financial Results and Conference Call

GlobeNewswire May 23, 2022

Correction: Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2021 Financial Results

GlobeNewswire April 29, 2022

Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2021 Financial Results

GlobeNewswire April 29, 2022

Aurora Spine Corporation Schedules Release for Fourth Quarter and Fiscal Year 2021 Financial Results and Conference Call

GlobeNewswire April 28, 2022

Aurora Spine Corporation to Participate in the Lytham Partners Spring 2022 Investor Conference

GlobeNewswire March 31, 2022

Aurora Spine Corporation Announces Initial Implantation of the World's First Bone Density Matched DEXA-C Cervical Interbody Fusion Device

GlobeNewswire March 3, 2022